Clinical trial

Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT

NCT05084079

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CSII with formula-based initial insulin regimen Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CSII with weight-based initial insulin regimen Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-11-01

PhasePHASE4

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Glucose Metabolism Disordersunresolved

Metabolic Diseaseverified · MONDO: metabolic disease

Endocrine System Diseasesunresolved

Interventions

CSII with formula-based initial insulin regimenDRUG

CSII with weight-based initial insulin regimenDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05084079 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.